¨ä¥L¤º¤Àªc¯e¯f±Ð¾Ç¡]±M·~ª©¡^

¬ü¤u¹Ï LogoOther Endocrine Diseases¬ü¤u¹Ï Logo
The Merck Manual of Endocrine and Metabolic Diseases¡]Merck Manual¤§¤º¤Àªc¥NÁ¯e¯f¤â¥U¡^
Addison's Disease¡]·R­}¥Í¤ó¯f¡^¡]NIDDK, USA¡^
Cushing's Syndrome¡]®wªY¤ó¯g­Ô¸s¡^ ¡]NIDDK, USA¡^
Cushing's Syndrome¡GReview¡]®wªY¤ó¯g­Ô¸s¡A1999¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Cushing's Disease¡]®wªY¤ó¯f¡^ ¡]°ª¶¯ºaÁ`°q¥ß´¼¡BªL¿³¤¤¡B§õÂíûiÂå®v¡AIn Chinese ¤¤¤åª©¡^
The Use of Steroid in Clinical Practice¡]Ãþ©T¾J¤§Á{§É¨Ï¥Î¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Adrenal corticosteroids¡]µÇ¤W¸¢¥Ö½èÃþ©T¾J¡^¡]¤¤µØ¥Á°ê½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
Hyperthyroidism & Hypothyroidism:AACE Guidelines¡]AACE¤§¥Òª¬¸¢¥\¯à¤®¶i¤Î§C¤U¯gªvÀø«ü¤Þ¡^
Evaluation of Thyroid Nodule: AACE Guidelines¡]¥Òª¬¸¢µ²¸`¤§³B²z¡^¡]AACE¤§¥Òª¬¸¢µ²¸`ªvÀø«ü¤Þ¡^
AACE¡GDiabetes Mellitus Gudieline 2007¡]2007¦~¿}§¿¯fªvÀø«ü¤Þ¡^¡]AACE¤§ªvÀø«ü¤Þ¡^
Thyroid Diseases and Pregnancy¡]¥Òª¬¸¢¯e¯f»PÃh¥¥¡^¡]¥x¤¤ºaÁ`ªL¨|¬Â¡B³\´f«íÂå®v¡AIn Chinese ¤¤¤åª©¡^
Thyroid Cancer¡]¥Òª¬¸¢Àù¡^ (°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©)
Thyroid Carcinoma: AACE Guidelines¡]AACE¤§¥Òª¬¸¢ÀùªvÀø«ü¤Þ¡^
Thyroid hormones¡ALevothyroxine¡AT4)¡]¥Òª¬¸¢¿E¯À¡^¡]¤¤µØ¥Á°ê½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
Antithyroid Drugs¡]§Ü¥Òª¬¸¢¿E¯À¾¯¡^¡]¤¤µØ¥Á°ê½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
Hyperparathyroidism¡]°Æ¥Òª¬¸¢¥\¯à¤®¶i¯g¡^¡]NIDDK¡^
(1)Prolactinoma¡]NIDDK¡^(2)ªc¨Å¿E¯À½F¡]°ª¶¯ºaÁ`°q¥ß´¼¡BªL¿³¤¤¡B§õÂíûiÂå®v¡AIn Chinese ¤¤¤åª©¡^
TSH-secreting tumor¡]¥Ò«P¯À¤Àªc½F¡^ ¡]°ª¶¯ºaÁ`°q¥ß´¼¡BªL¿³¤¤¡B§õÂíûiÂå®v¡AIn Chinese ¤¤¤åª©¡^
Acromegaly¡]ªÏºÝªÎ¤j¯g¡^¡]°ª¶¯ºaÁ`°q¥ß´¼¡BªL¿³¤¤¡B§õÂíûiÂå®v¡AIn Chinese ¤¤¤åª©¡^
Acromegaly¡]ªÏºÝªÎ¤j¯g¡^¡]NIDDK¡^
Acromegaly: AACE Guidelines¡]AACE¤§ªÏºÝªÎ¤j¯gªvÀø«ü¤Þ¡^
Non-functioning Pituitary Tumors¡]µL¤º¤Àªc¬¡©Êªº¸£¤U««Å鸢½F¡^¡]°ª¶¯ºaÁ`°q¥ß´¼¡BªL¿³¤¤¡B§õÂíûiÂå®v¡AIn Chinese ¤¤¤åª©¡^
Neuroendocrine Lectures¡]¯«¸g¤º¤Àªc¾Ç¡^¡]Massachusetts General Hospital Neuroendocrine Clinical Center¡^
Bromocriptine Mesylate¡]§@¥Î©ó¸£¤U¸¢«e¸­»P¤Uµø¥CªºÃĪ«¡^¡]¤¤µØ¥Á°ê½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
Osteoporosis-Review in 2002¡]°©½è²¨ÃP¯g¤§³Ìªñ¶i®i¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Pathogenesis of Osteoporosis¡]°©½è²¨ÃP¯g¤§¦¨¦]¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Postmenopausal Osteoporosis: AACE Guideline¡]AACE¤§°±¸g«á°©½è²¨ÃP¯g«ü¤Þ¡^
The Merck Manual on Osteoporosis¡]Merck Manual °©½è²¨ÃP¯g¤â¥U¡^
AACE¡GClinical practice for management of menopause¡]°±¸g°ü¤k¤§³B²z¡^¡]AACE¤§°±¸g°ü¤k³B²z«ü¤Þ¡^
Estrogens, Progestins & Others¡]°Ê±¡¿E¯À¡B¶ÀÅé¿E¯À¤ÎªvÀø¤£¥¥¯gÃĪ«¡^¡]½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
MEN-Type 1¡]²Ä¤@«¬¦hµo©Ê¤º¤Àªc½F¡^¡]NIDDK¡^
Hyperandrogenic disorders¡]¨k©Ê©Ê¸¢¥\¯à¹L°ª¯g¡^¡]AACE¤§¨k©Ê©Ê¸¢¥\¯à¹L°ª¯gªvÀø«ü¤Þ¡^
Male Hypogonadism: AACE Guideline¡]¨k©Ê©Ê¥\¯à§C¤U¯g¡^¡]AACE¤§¨k©Ê©Ê¥\¯à§C¤U¯gªvÀø«ü¤Þ¡^
Male Sexual Dysfunction: AACE Guideline¡]¨k©Ê©Ê¥\¯à²§±`¡^¡]AACE¤§¨k©Ê©Ê¥\¯à²§±`«ü¤Þ¡^
Androgens and Anabolic Steroids¡]¶¯©Ê¿E¯À»P¦P¤Æ§@¥ÎÃþ©T¾J¡^¡]¤¤µØ¥Á°ê½Ã¥Í¸p¡AIn Chinese ¤¤¤åª©¡^
Introduction to "Endothelin"¡]¤º¥Ö¯À¤¶²Ð¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
°h¶Â¿E¯À¡AMelatonin¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Thyrotoxic periodic paralysis¡]¥Òª¬¸¢¬r©Ê¶g´Á©Ê³Â·ô¯g¡^¡]°ª¶¯ºaÁ`ªL¿³¤¤Âå®v¡AIn Chinese ¤¤¤åª©¡^
Leptin¡]ªÎ­D³J¥Õ½è¡G½GÅé¯À¡^¡]¥x¤¤ºaÁ`·s³¯¥NÁ¬ì¡AIn Chinese ¤¤¤åª©¡^
Pediatric Endocrine Diseases¡]¨àµ£¤º¤Àªc¯e¯f¡^¡]ªø©°¨àµ£Âå°|¤º¤Àªc¬ìùºÖªQÂå®v ¡AIn Chinese ¤¤¤åª©¡^
Growth Hormone Use in Adults and Children¡]¥Íªø¿E¯À¦b¦¨¤H¤Î¤p«Ä¤§Á{§É¨Ï¥Î¡^¡]AACE¤§¥Íªø¿E¯ÀÁ{§ÉªvÀø«ü¤Þ¡^
Diagnosis and Treatment of Dyslipidemia¡]¦å¯×²§±`¤§¶EÂ_»PªvÀø«ü¤Þ¡^¡]AACE¦å¯×²§±`¤§¶EÂ_»PªvÀø«ü¤Þ¡^
Other Endocrine Resources¡]¥þ²y¨ä¥L¤º¤Àªcºô¯¸¡^¡]¥²¬Ý¡I¡^

¬ü¤u¹Ï Logo

¬ü¤u¹Ï LogoªL ¿³ ¤¤ Âå®v ¬ü¤u¹Ï LogoDr. Hing-Chung Lam